CITIUS ONCOLOGY, INC. (CTOR)
↓ Download CSVKey ratios (FY2025)
-55.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Income | -$23.52M | -$20.57M | -$1.01M | -$138.1K | — |
| Net Income | -$24.76M | -$21.15M | $2.42M | $380.8K | — |
| EPS (Diluted) | $-0.34 | $-0.31 | $0.27 | $0.12 | — |
| Total Assets | $100.94M | $84.37M | $72.62M | $68.19M | $126.4K |
| Total Liabilities | $56.08M | $38.23M | $22.20M | — | — |
| Shareholders' Equity | $44.87M | $46.14M | -$1.99M | $345.5K | -$10.1K |
| Operating Cash Flow | -$5.49M | $126.4K | -$601.3K | -$48.0K | — |
| Shares Outstanding | 83.51M | 71.55M | 2.34M | 2.42M | 2.42M |